Tag Archives: Helps

Chi-Med, AstraZeneca’s savolitinib helps some Tagrisso-resistant EGFR lung cancer patients

ATLANTA—AstraZeneca’s Tagrisso has taken the EGFR lung cancer market by storm, but some patients develop resistance to the therapy. Enter Chi-Med. The Chinese company Sunday rolled out phase 1b results showing that certain treatment-resistant patients showed improvement after receiving a combination of Tagrisso, which targets the EGFR gene mutation, and Chi-Med’s savolitinib, a MET inhibitor… Read More »

Acupressure Helps Relieve Breast Cancer Treatment Symptoms (STUDY)

A study has found that acupressure could be a low-cost, DIY solution for a set of persistent side effects which remain after conventional treatment for breast cancer is completed. It was reported by researchers in 2016 that acupressure helped with a reduction of fatigue in breast cancer survivors. This current study examined how acupressure impacted… Read More »